Latest News

Testosterone replacement therapy may not increase risk of prostate cancer among men with hypogonadism

The impact of testosterone replacement therapy (TRT) on prostate…

Liso-cel cost effective second-line treatment for common form of lymphoma

Lisocabtagene maraleucel (liso-cel), a CAR T-cell therapy, is…

CKD predicts incomplete revascularization and subsequent MACE in CCS patients

Egypt: Chronic kidney disease predicts partial revascularization…
Facebook Comments